National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 27460-27461 [2021-10626]
Download as PDF
<![CDATA[
27460
Federal Register / Vol. 86, No. 96 / Thursday, May 20, 2021 / Notices
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Nutrition for
Precision Health, powered by the All of Us
Research Program: Microbiome and
Metagenomics Center (U24).
Date: June 16, 2021.
Time: 10:00 a.m. to 5:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Allen Richon, Ph.D.,
Scientific Review Officer, Center for
Scientific Review National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, 301–379–
9351, allen.richon@nih.hhs.gov.
Name of Committee: Biobehavioral and
Behavioral Processes, Integrated Review
Group Child Psychopathology and
Developmental Disabilities Study Section.
Date: June 17–18, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Katherine Colona Morasch,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3170,
Bethesda, MD 20892, moraschkc@
csr.nih.gov.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group
Social Sciences and Population Studies B
Study Section.
Date: June 17–18, 2021.
Time: 9:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Kate Fothergill, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3142,
Bethesda, MD 20892, 301–435–2309,
fothergillke@mail.nih.gov.
Name of Committee: Vascular and
Hematology Integrated Review Group
Hemostasis, Thrombosis, Blood Cells and
Transfusion Study Section.
Date: June 17–18, 2021.
Time: 10:00 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:36 May 19, 2021
Jkt 253001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Ai-Ping Zou, M.D. Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4118,
MSC 7814, Bethesda, MD 20892, (301) 408–
9497, zouai@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel Small
Business: Musculoskeletal, Orthopedic, Oral,
Rehabilitation and Dermatology.
Date: June 21–23, 2021.
Time: 8:30 a.m. to 8:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Aftab A Ansari, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 4108,
MSC 7814, Bethesda, MD 20892, (301) 237–
9931, ansaria@csr.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS)
Dated: May 14, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10627 Filed 5–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Neurological
Disorders and Stroke; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Neurological Disorders and Stroke Special
Emphasis Panel; Translational Neural, Brain,
and Pain Relief Devices
Date: June 21, 2021.
Time: 1:30 p.m. to 4:30 p.m.
PO 00000
Frm 00097
Fmt 4703
Sfmt 4703
Agenda: To review and evaluate
cooperative agreement applications.
Place: National Institutes of Health,
Neuroscience Center, 6001 Executive
Boulevard, Rockville, MD 20852 (Virtual
Meeting).
Contact Person: Diana M. Cummings,
Ph.D., Scientific Review Officer, Scientific
Review Branch, National Institute of
Neurological Disorders and Stroke, NIH NSC,
6001 Executive Blvd., Suite 3208, Rockville,
MD 20852, cummingsdi@ninds.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.853, Clinical Research
Related to Neurological Disorders; 93.854,
Biological Basis Research in the
Neurosciences, National Institutes of Health,
HHS)
Dated: May 14, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10624 Filed 5–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Coccidioidomycosis
Collaborative Research Centers (U19 Clinical
Trial Not Allowed).
Date: June 23–25, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F21,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Annie Walker-Abbey,
Ph.D., Scientific Review Officer, Scientific
Review Program, Division of Extramural
Activities, National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3F21,
Rockville, MD 20852, 240–627–3390,
aabbey@niaid.nih.gov.
E:\FR\FM\20MYN1.SGM
20MYN1
Federal Register / Vol. 86, No. 96 / Thursday, May 20, 2021 / Notices
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: May 14, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2021–10626 Filed 5–19–21; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF THE INTERIOR
Fish and Wildlife Service
[FWS–HQ–ES–2021–N158; FF09E20000
FXES1111090FEDR 212; OMB Control
Number 1018–0119]
Agency Information Collection
Activities; Policy for Evaluation of
Conservation Efforts When Making
Listing Decisions (PECE)
Fish and Wildlife Service,
Interior.
ACTION: Notice of information collection;
request for comment.
AGENCY:
In accordance with the
Paperwork Reduction Act of 1995
(PRA), we, the U.S. Fish and Wildlife
Service (Service), are proposing to
renew an information collection.
DATES: Interested persons are invited to
submit comments on or before July 19,
2021.
ADDRESSES: Send written comments on
this information collection request (ICR)
to the Service Information Collection
Clearance Officer, U.S. Fish and
Wildlife Service, MS: PRB (JAO/3W),
5275 Leesburg Pike, Falls Church, VA
22041–3803 (mail); or by email to Info_
Coll@fws.gov. Please reference OMB
Control Number 1018–0119 in the
subject line of your comments.
FOR FURTHER INFORMATION CONTACT:
Madonna L. Baucum, Service
Information Collection Clearance
Officer, by email at Info_Coll@fws.gov,
or by telephone at (703) 358–2503.
Individuals who are hearing or speech
impaired may call the Federal Relay
Service at 1–800–877–8339 for TTY
assistance.
SUMMARY:
In
accordance with the PRA and its
implementing regulations at 5 CFR
1320.8(d)(1), all information collections
require approval under the PRA.
As part of our continuing effort to
reduce paperwork and respondent
SUPPLEMENTARY INFORMATION:
VerDate Sep<11>2014
17:36 May 19, 2021
Jkt 253001
burdens, we invite the public and other
Federal agencies to comment on new,
proposed, revised, and continuing
collections of information. This helps us
assess the impact of our information
collection requirements and minimize
the public’s reporting burden. It also
helps the public understand our
information collection requirements and
provide the requested data in the
desired format.
We are especially interested in public
comment addressing the following:
(1) Whether or not the collection of
information is necessary for the proper
performance of the functions of the
agency, including whether or not the
information will have practical utility;
(2) The accuracy of our estimate of the
burden for this collection of
information, including the validity of
the methodology and assumptions used;
(3) Ways to enhance the quality,
utility, and clarity of the information to
be collected; and
(4) How might the agency minimize
the burden of the collection of
information on those who are to
respond, including through the use of
appropriate automated, electronic,
mechanical, or other technological
collection techniques or other forms of
information technology, e.g., permitting
electronic submission of response.
Comments that you submit in
response to this notice are a matter of
public record. We will include or
summarize each comment in our request
to OMB to approve this ICR. Before
including your address, phone number,
email address, or other personal
identifying information in your
comment, you should be aware that
your entire comment—including your
personal identifying information—may
be made publicly available at any time.
While you can ask us in your comment
to withhold your personal identifying
information from public review, we
cannot guarantee that we will be able to
do so.
Abstract: Section 4 of the Endangered
Species Act (ESA; 16 U.S.C. 1531 et
seq.) outlines the process by which we
can list a species as a threatened species
or an endangered species. When we
consider whether to list a species, the
ESA requires us to take into account the
efforts made by any State or any
political subdivision of a State to protect
such species. We also take into account
the efforts made by other entities. States
or other entities often formalize
conservation efforts in conservation
agreements, conservation plans,
PO 00000
Frm 00098
Fmt 4703
Sfmt 4703
27461
management plans, or similar
documents. The conservation efforts
recommended or described in such
documents could prevent some species
from becoming so imperiled that they
meet the definition of a threatened
species or an endangered species under
the ESA.
The Policy for Evaluation of
Conservation Efforts When Making
Listing Decisions (PECE) (68 FR 15100,
March 28, 2003) encourages the
development of conservation
agreements or plans and provides the
standard that an individual
conservation effort must meet in order
for us to consider whether it is likely to
make a difference in a species’ status.
PECE applies to formalized conservation
efforts that have not been implemented
or have been implemented but have not
yet demonstrated if they are effective at
the time of a listing decision.
Under PECE, formalized conservation
efforts are defined as conservation
efforts (specific actions, activities, or
programs designed to eliminate or
reduce threats or otherwise improve the
status of a species) identified in a
conservation agreement, conservation
plan, management plan, or similar
document. To assist us in evaluating
whether a formalized conservation effort
meets the standard under PECE, we
collect information such as conservation
plans, monitoring results, and progress
reports. The development of any
agreement or plan is voluntary. The
PECE is posted on our Candidate
Conservation website at https://
www.fws.gov/endangered/esa-library/
pdf/PECE-final.pdf.
Title of Collection: Policy for
Evaluation of Conservation Efforts
When Making Listing Decisions (PECE).
OMB Control Number: 1018–0119.
Form Number: None.
Type of Review: Extension without
change of a currently approved
collection.
Respondents/Affected Public:
Primarily State, local, or Tribal
governments. However, individuals,
businesses, and not-for-profit
organizations also could develop
agreements/plans or may agree to
implement certain conservation efforts
identified in a State agreement or plan.
Respondent’s Obligation: Required to
obtain or retain a benefit.
Frequency of Collection: On occasion.
Total Estimated Annual Nonhour
Burden Cost: None.
E:\FR\FM\20MYN1.SGM
20MYN1
]]>Agencies
[Federal Register Volume 86, Number 96 (Thursday, May 20, 2021)]
[Notices]
[Pages 27460-27461]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2021-10626]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Coccidioidomycosis Collaborative
Research Centers (U19 Clinical Trial Not Allowed).
Date: June 23-25, 2021.
Time: 9:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F21,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Annie Walker-Abbey, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3F21,
Rockville, MD 20852, 240-627-3390, [email protected].
[[Page 27461]]
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: May 14, 2021.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2021-10626 Filed 5-19-21; 8:45 am]
BILLING CODE 4140-01-P
